Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Covidien, a provider of healthcare products, has filed a lawsuit in the US District Court of Delaware against Davol, a wholly owned subsidiary of CR Bard, relating to its mesh fixation device and applier.
Subscribe to our email newsletter
The lawsuit contends that Davol’s recently released Sorbafix device infringes multiple claims of Covidien’s US patent.
The patent generally relates to a system for controllably discharging fasteners from an applicator. Covidien is asking the federal court to enjoin Davol from continuing to make and sell its Sorbafix device, as well as for compensatory damages.
Dave Motley, responsible for global surgical franchise and portfolio management at Covidien, said: “We will vigorously protect our intellectual property.”